{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Ozone", "airway hyperresponsiveness", "group 2 innate lymphoid cells"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "26282284", "DateCompleted": {"Year": "2016", "Month": "06", "Day": "30"}, "DateRevised": {"Year": "2023", "Month": "07", "Day": "18"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2015", "Month": "08", "Day": "15"}], "ELocationID": ["10.1016/j.jaci.2015.06.037", "S0091-6749(15)00936-7"], "Journal": {"ISSN": "1097-6825", "JournalIssue": {"Volume": "137", "Issue": "2", "PubDate": {"Year": "2016", "Month": "Feb"}}, "Title": "The Journal of allergy and clinical immunology", "ISOAbbreviation": "J Allergy Clin Immunol"}, "ArticleTitle": "Group 2 innate lymphoid cells mediate ozone-induced airway inflammation and hyperresponsiveness in mice.", "Pagination": {"StartPage": "571", "EndPage": "578", "MedlinePgn": "571-8"}, "Abstract": {"AbstractText": ["Asthmatic patients are highly susceptible to air pollution and in particular to the effects of ozone (O3) inhalation, but the underlying mechanisms remain unclear.", "Using mouse models of O3-induced airway inflammation and airway hyperresponsiveness (AHR), we sought to investigate the role of the recently discovered group 2 innate lymphoid cells (ILC2s).", "C57BL/6 and BALB/c mice were exposed to Aspergillus fumigatus, O3, or both (3 ppm for 2 hours). ILC2s were isolated by means of fluorescence-activated cell sorting and studied for Il5 and Il13 mRNA expression. ILC2s were depleted with anti-Thy1.2 mAb and replaced by means of intratracheal transfer of ex\u00a0vivo expanded Thy1.1 ILC2s. Cytokine levels (ELISA and quantitative PCR), inflammatory cell profile, and AHR (flexiVent) were assessed in the mice.", "In addition to neutrophil influx, O3 inhalation elicited the appearance of eosinophils and IL-5 in the airways of BALB/c but not C57BL/6 mice. Although O3-induced expression of IL-33, a known activator of ILC2s, in the lung was similar between these strains, isolated pulmonary ILC2s from O3-exposed BALB/c mice had significantly greater Il5 and Il13 mRNA expression than C57BL/6 mice. This suggested that an altered ILC2 function in BALB/c mice might mediate the increased O3 responsiveness. Indeed, anti-Thy1.2 treatment abolished but ILC2s added back dramatically enhanced O3-induced AHR.", "O3-induced activation of pulmonary ILC2s was necessary and sufficient to mediate asthma-like changes in BALB/c mice. This previously unrecognized role of ILC2s might help explain the heightened susceptibility of human asthmatic airways to O3 exposure."], "CopyrightInformation": "Copyright \u00a9 2015 American Academy of Allergy, Asthma & Immunology. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pa; T-Cell Biology and Development Section, Laboratory of Genome Integrity, National Cancer Institute, National Institutes of Health, Bethesda, Md."}], "LastName": "Yang", "ForeName": "Qi", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pulmonary, Allergy and Critical Care Division, Department of Medicine, University of Pennsylvania, Philadelphia, Pa; Translational Lung Biology Center, Pulmonary, Critical Care & Sleep Medicine, University of California, Davis, Calif; Department of Microbiology, National University of Singapore, Singapore."}], "LastName": "Ge", "ForeName": "Moyar Q", "Initials": "MQ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pulmonary, Allergy and Critical Care Division, Department of Medicine, University of Pennsylvania, Philadelphia, Pa."}], "LastName": "Kokalari", "ForeName": "Blerina", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pulmonary, Allergy and Critical Care Division, Department of Medicine, University of Pennsylvania, Philadelphia, Pa."}], "LastName": "Redai", "ForeName": "Imre G", "Initials": "IG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pa."}], "LastName": "Wang", "ForeName": "Xinxin", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, National University of Singapore, Singapore."}], "LastName": "Kemeny", "ForeName": "David M", "Initials": "DM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pa; T-Cell Biology and Development Section, Laboratory of Genome Integrity, National Cancer Institute, National Institutes of Health, Bethesda, Md. Electronic address: avinash.bhandoola@nih.gov."}], "LastName": "Bhandoola", "ForeName": "Avinash", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pulmonary, Allergy and Critical Care Division, Department of Medicine, University of Pennsylvania, Philadelphia, Pa; Translational Lung Biology Center, Pulmonary, Critical Care & Sleep Medicine, University of California, Davis, Calif. Electronic address: haczku@ucdavis.edu."}], "LastName": "Haczku", "ForeName": "Angela", "Initials": "A"}], "GrantList": [{"GrantID": "R21 AI059621", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "RC1 ES018505", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "AI098428", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "R01 AI059621", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "R01AI072197", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "R56 AI059621", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "R01 AI072197", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "P30 ES013508", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R21 AI098428", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "RC1ES018505", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "P30ES013508", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Allergy Clin Immunol", "NlmUniqueID": "1275002", "ISSNLinking": "0091-6749"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Allergens"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": ["immunology"], "DescriptorName": "Allergens"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Environmental Exposure"}, {"QualifierName": ["etiology"], "DescriptorName": "Eosinophilia"}, {"QualifierName": [], "DescriptorName": "Immunity, Innate"}, {"QualifierName": ["immunology"], "DescriptorName": "Lymphocyte Activation"}, {"QualifierName": ["immunology", "metabolism"], "DescriptorName": "Lymphocyte Subsets"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Respiratory Function Tests"}, {"QualifierName": ["etiology", "pathology", "physiopathology"], "DescriptorName": "Respiratory Hypersensitivity"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ledford DK, Burks AW, Ballow M, Cox L, Wood RA, Casale TB. Statement regarding. \"The public health benefits of air pollution control\". J Allergy Clin Immunol. 2012;130:24.", "ArticleIdList": ["22742836"]}, {"Citation": "Li J, Ewart G, Kraft M, Finn PW. The public health benefits of air pollution control. J Allergy Clin Immunol. 2012;130:22\u201323.", "ArticleIdList": ["22521246"]}, {"Citation": "Kim KH, Jahan SA, Kabir E. A review on human health perspective of air pollution with respect to allergies and asthma. Environ Int. 2013;59:41\u201352.", "ArticleIdList": ["23770580"]}, {"Citation": "Peel JL, Tolbert PE, Klein M, Metzger KB, Flanders WD, Todd K, et al. Ambient air pollution and respiratory emergency department visits. Epidemiology. 2005;16:164\u2013174.", "ArticleIdList": ["15703530"]}, {"Citation": "Bosson J, Stenfors N, Bucht A, Helleday R, Pourazar J, Holgate ST, et al. Ozone-induced bronchial epithelial cytokine expression differs between healthy and asthmatic subjects. Clin Exp Allergy. 2003;33:777\u2013782.", "ArticleIdList": ["12801312"]}, {"Citation": "Frischer T, Studnicka M, Halmerbauer G, Horak F, Jr, Gartner C, Tauber E, et al. Ambient ozone exposure is associated with eosinophil activation in healthy children. Clin Exp Allergy. 2001;31:1213\u20131219.", "ArticleIdList": ["11529890"]}, {"Citation": "Kierstein S, Krytska K, Sharma S, Amrani Y, Salmon M, Panettieri RA, Jr, et al. Ozone inhalation induces exacerbation of eosinophilic airway inflammation and hyperresponsiveness in allergen-sensitized mice. Allergy. 2008;63:438\u2013446.", "ArticleIdList": ["18315731"]}, {"Citation": "Lee JJ, Dimina D, Macias MP, Ochkur SI, McGarry MP, O'Neill KR, et al. Defining a link with asthma in mice congenitally deficient in eosinophils. Science. 2004;305:1773\u20131776.", "ArticleIdList": ["15375267"]}, {"Citation": "Humbles AA, Lloyd CM, McMillan SJ, Friend DS, Xanthou G, McKenna EE, et al. A critical role for eosinophils in allergic airways remodeling. Science. 2004;305:1776\u20131779.", "ArticleIdList": ["15375268"]}, {"Citation": "Yang Q, Monticelli LA, Saenz SA, Chi AW, Sonnenberg GF, Tang J, et al. T cell factor 1 is required for group 2 innate lymphoid cell generation. Immunity. 2013;38:694\u2013704.", "ArticleIdList": ["PMC4029843", "23601684"]}, {"Citation": "Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, Doering TA, et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol. 2011;12:1045\u20131054.", "ArticleIdList": ["PMC3320042", "21946417"]}, {"Citation": "Chang YJ, Kim HY, Albacker LA, Baumgarth N, McKenzie AN, Smith DE, et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol. 2011;12:631\u2013638.", "ArticleIdList": ["PMC3417123", "21623379"]}, {"Citation": "Halim TY, Krauss RH, Sun AC, Takei F. Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity. 2012;36:451\u2013463.", "ArticleIdList": ["22425247"]}, {"Citation": "Bartemes KR, Iijima K, Kobayashi T, Kephart GM, McKenzie AN, Kita H. IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J Immunol. 2012;188:1503\u20131513.", "ArticleIdList": ["PMC3262877", "22198948"]}, {"Citation": "Barlow JL, Bellosi A, Hardman CS, Drynan LF, Wong SH, Cruickshank JP, et al. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J Allergy Clin Immunol. 2012;129:191\u2013198. e1\u2013e4.", "ArticleIdList": ["22079492"]}, {"Citation": "Price AE, Liang HE, Sullivan BM, Reinhardt RL, Eisley CJ, Erle DJ, et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci U S A. 2010;107:11489\u201311494.", "ArticleIdList": ["PMC2895098", "20534524"]}, {"Citation": "Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TK, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010;464:1367\u20131370.", "ArticleIdList": ["PMC2862165", "20200518"]}, {"Citation": "Mjosberg J, Spits H. Type 2 innate lymphoid cells-new members of the \"type 2 franchise\" that mediate allergic airway inflammation. Eur J Immunol. 2012;42:1093\u20131096.", "ArticleIdList": ["22539283"]}, {"Citation": "Mjosberg JM, Trifari S, Crellin NK, Peters CP, van Drunen CM, Piet B, et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol. 2011;12:1055\u20131062.", "ArticleIdList": ["21909091"]}, {"Citation": "Mohrs M, Shinkai K, Mohrs K, Locksley RM. Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. Immunity. 2001;15:303\u2013311.", "ArticleIdList": ["11520464"]}, {"Citation": "Hatch GE, Slade R, Harris LP, McDonnell WF, Devlin RB, Koren HS, et al. Ozone dose and effect in humans and rats. A comparison using oxygen-18 labeling and bronchoalveolar lavage. Am J Respir Crit Care Med. 1994;150:676\u2013683.", "ArticleIdList": ["8087337"]}, {"Citation": "Slade R, Watkinson WP, Hatch GE. Mouse strain differences in ozone dosimetry and body temperature changes. Am J Physiol. 1997;272:L73\u2013L77.", "ArticleIdList": ["9038905"]}, {"Citation": "Jain D, Keslacy S, Tliba O, Cao Y, Kierstein S, Amin K, et al. Essential role of IFNbeta and CD38 in TNFalpha-induced airway smooth muscle hyper-responsiveness. Immunobiology. 2008;213:499\u2013509.", "ArticleIdList": ["PMC2587232", "18514752"]}, {"Citation": "Zhang Y, Lamm WJ, Albert RK, Chi EY, Henderson WR, Jr, Lewis DB. Influence of the route of allergen administration and genetic background on the murine allergic pulmonary response. Am J Respir Crit Care Med. 1997;155:661\u2013669.", "ArticleIdList": ["9032210"]}, {"Citation": "McConnell R, Berhane K, Gilliland F, London SJ, Islam T, Gauderman WJ, et al. Asthma in exercising children exposed to ozone: a cohort study. Lancet. 2002;359:386\u2013391.", "ArticleIdList": ["11844508"]}, {"Citation": "Scannell C, Chen L, Aris RM, Tager I, Christian D, Ferrando R, et al. Greater ozone-induced inflammatory responses in subjects with asthma. Am J Respir Crit Care Med. 1996;154:24\u201329.", "ArticleIdList": ["8680687"]}, {"Citation": "Koren HS. Associations between criteria air pollutants and asthma. Environ Health Perspect. 1995;103(Suppl 6):235\u2013242.", "ArticleIdList": ["PMC1518942", "8549479"]}, {"Citation": "Atochina EN, Beers MF, Tomer Y, Scanlon ST, Russo SJ, Panettieri RA, Jr, et al. Attenuated allergic airway hyperresponsiveness in C57BL/6 mice is associated with enhanced surfactant protein (SP)-D production following allergic sensitization. Respir Res. 2003;4:15.", "ArticleIdList": ["PMC314399", "14748931"]}, {"Citation": "Takeda K, Haczku A, Lee JJ, Irvin CG, Gelfand EW. Strain dependence of airway hyperresponsiveness reflects differences in eosinophil localization in the lung. Am J Physiol Lung Cell Mol Physiol. 2001;281:L394\u2013L402.", "ArticleIdList": ["11435214"]}, {"Citation": "Zhang LY, Levitt RC, Kleeberger SR. Differential susceptibility to ozone-induced airways hyperreactivity in inbred strains of mice. Exp Lung Res. 1995;21:503\u2013518.", "ArticleIdList": ["7588439"]}, {"Citation": "Ishi Y, Shirato M, Nomura A, Sakamoto T, Uchida Y, Ohtsuka M, et al. Cloning of rat eotaxin: ozone inhalation increases mRNA and protein expression in lungs of brown Norway rats. Am J Physiol. 1998;274:L171\u2013L176.", "ArticleIdList": ["9458816"]}, {"Citation": "Johnston RA, Mizgerd JP, Flynt L, Quinton LJ, Williams ES, Shore SA. Type I interleukin-1 receptor is required for pulmonary responses to subacute ozone exposure in mice. Am J Respir Cell Mol Biol. 2007;37:477\u2013484.", "ArticleIdList": ["PMC2176124", "17575079"]}, {"Citation": "Yang Q, Saenz SA, Zlotoff DA, Artis D, Bhandoola A. Cutting edge: Natural helper cells derive from lymphoid progenitors. J Immunol. 2011;187:5505\u20135509.", "ArticleIdList": ["PMC3548425", "22025549"]}, {"Citation": "Gao YD, Zou JJ, Zheng JW, Shang M, Chen X, Geng S, et al. Promoting effects of IL-13 on Ca2+ release and store-operated Ca2+ entry in airway smooth muscle cells. Pulm Pharmacol Ther. 2010;23:182\u2013189.", "ArticleIdList": ["20045483"]}, {"Citation": "Kim HY, Chang YJ, Subramanian S, Lee HH, Albacker LA, Matangkasombut P, et al. Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J Allergy Clin Immunol. 2012;129:216\u2013227. e1\u2013e6.", "ArticleIdList": ["PMC3246069", "22119406"]}], "ReferenceList": []}], "History": [{"Year": "2014", "Month": "11", "Day": "11"}, {"Year": "2015", "Month": "6", "Day": "9"}, {"Year": "2015", "Month": "6", "Day": "29"}, {"Year": "2015", "Month": "8", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "8", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "7", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "2", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["26282284", "NIHMS716509", "PMC4747855", "10.1016/j.jaci.2015.06.037", "S0091-6749(15)00936-7"]}}], "PubmedBookArticle": []}